德視佳(01846.HK)購德國眼科業務 拓晶體置換手術領域
德視佳(01846.HK)公布,其全資擁有的EuroEyes KG向Knorz GmbH收購FreeVis GmbH全部股權,總代價的最高金額約為518.07萬歐元。
另外,EuroEyes KG向Knorz收購PMK,代價最多為736.12萬歐元。就PMK收購事項而言,EuroEyes KG將向FreeVis GmbH提供515.29萬歐元年利率3厘計息貸款。而EuroEyes KG將就PMK收購事項購買價的付款責任提供不逾220.84萬歐元作為擔保。
FreeVis GmbH於德國曼海姆經營一間眼科診所,以檢查、預防及治療視力缺陷,並專門提供屈光性激光手術。除SmartSurf PRK、Femto-LASIK及SMILE外,FreeVis GmbH的主要重點是植入人工晶體(Visian ICL)及植入三焦點人工晶體的屈光晶體置換。
PMK為一間德國眼科私人執業公司,專門從事晶體置換手術。
公司認為,隨著FreeVis GmbH及PMK業務併入集團,集團擬擴大其於德國曼海姆的現有業務,同時提升其於德國的整體市場領導地位。此外,FreeVis GmbH及PMK的醫療執業將提供全方位眼科服務,涵蓋提供晶體置換手術及屈光手術,亦與集團提供的服務一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.